✦ LIBER ✦

Teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPS trial

✍ Scribed by C.C. Glüer⁎; F. Marin; J.D. Ringe; F. Hawkins; R. Möricke; N. Papaioannu; P. Farahmand; S. Minisola; G. Martínez; J.M. Nolla; C. Niedhart; N. Guañabens; R. Nuti; E. Martín-Mola; F. Thomasius; G. Kapetanos; J. Peña; C. Graeff; H. Petto; B. Sanz; A. Reisinger; P. Zysset

Book ID: 116325214
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 96 KB
Volume: 50
Category: Article
ISSN: 8756-3282
DOI: 10.1016/j.bone.2012.02.106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bisphosphonates and glucocorticoid osteo

Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate

✍ Philip N. Sambrook; Christian Roux; Jean-Pierre Devogelaer; Kenneth Saag; Chak-S 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 462 KB

Sequential use of teriparatide and rised

Sequential use of teriparatide and risedronate in multifractured severe osteoporosis: Clinical results at 30 month F.U

✍ C. Corradini; M. Macchia; E. Malagoli; A. Elli; A. Sigismondi; C. Crapanzano; F. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Active comparator trial of teriparatide

Active comparator trial of teriparatide versus alendronate in the treatment of glucocorticoid-induced osteoporosis

✍ Taylor, Kathleen A.; Saag, Kenneth G.; Shane, Elizabeth; Boonen, Steven; Donley, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 87 KB

Effects of teriparatide versus alendrona

Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: Thirty-six–month results of a randomized, double-blind, controlled trial

✍ Kenneth G. Saag; Jose R. Zanchetta; Jean-Pierre Devogelaer; Robert A. Adler; Ric 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views

## Abstract ## Objective To compare the bone anabolic drug teriparatide (20 μg/day) with the antiresorptive drug alendronate (10 mg/day) for treating glucocorticoid‐induced osteoporosis (OP). ## Methods This was a 36‐month, randomized, double‐blind, controlled trial in 428 subjects with OP (ages

Active Comparator Trial of Teriparatide

Active Comparator Trial of Teriparatide vs Alendronate for Treating Glucocorticoid-Induced Osteoporosis: Results From the Hispanic and Non-Hispanic Cohorts

✍ Losada, Benito R.; Zanchetta, Jose R.; Zerbini, Cristiano; Molina, Jose F.; De l 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Bisphosphonates and glucocorticoid osteo

Bisphosphonates and glucocorticoid osteoporosis in premenopausal women: Results of a randomized controlled trial comparing zoledronic acid with risedronate

✍ D.M. Reid⁎; C. Roux; J.-P. Devogelaer; K. Saag; C.-S. Lau; J.-Y. Reginster; C. B 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 73 KB